SAN FRANCISCO, Dec. 18, 2017 -- Zephyr Health, the leading Insights-as-a-Service solution provider for Life Sciences companies, today announced that Zephyr Illuminate™ has been selected as one of the Top Innovative Products of 2017 by PM360. As featured in PM360’s annual Innovation issue, Relationship Analytics, a new ground-breaking capability of Zephyr Illuminate, was recognized for its ability to help Biopharma companies unlock the value of customer relationship networks to improve commercial efforts.
Relationship Analytics is designed to put a physician’s network into medical and market context based on type, importance, and strength of relevant connections. The insights generated by Relationship Analytics bridge the gap between disparate data and actionable next steps for more effective stakeholder engagement and decision-making.
“We are honored by PM360’s industry recognition of Relationship Analytics,” said William King, Founder and Executive Chairman, Zephyr Health. “This award caps off a successful year for Zephyr Health, in which we broadened the capabilities of Zephyr Illuminate, expanded the mobile platform to iPhone, and welcomed new Top 50 Biopharma and Medical Device customers. We look forward to continuing this momentum in 2018 and bringing innovative products to Life Sciences companies that deliver a sustainable competitive edge.”
About Zephyr Health
Zephyr Health helps Life Sciences companies – pharmaceutical, biotech, medical device and diagnostics – engage the right physicians, accounts and institutions using insights from global health data. Zephyr Illuminate™ is a leading Insights-as-a-Service solution that integrates thousands of data sources to create precise and predictive insights. From pre-launch to product maturity, Life Sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures. For more information, please visit: www.zephyrhealth.com.
Media Contact:
[email protected]


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Instagram Outage Disrupts Thousands of U.S. Users
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Washington Post Publisher Will Lewis Steps Down After Layoffs
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



